XWELL PE Ratio 2010-2025 | XWEL
Current and historical p/e ratio for XWELL (XWEL) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. XWELL PE ratio as of August 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| XWELL PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-20 | 1.10 | 0.00 | |
| 2025-06-30 | 0.92 | $-4.10 | 0.00 |
| 2025-03-31 | 1.02 | $-4.02 | 0.00 |
| 2024-12-31 | 1.51 | $-3.62 | 0.00 |
| 2024-09-30 | 1.73 | $-3.64 | 0.00 |
| 2024-06-30 | 1.80 | $-5.03 | 0.00 |
| 2024-03-31 | 1.69 | $-5.95 | 0.00 |
| 2023-12-31 | 1.74 | $-6.75 | 0.00 |
| 2023-09-30 | 2.25 | $-8.18 | 0.00 |
| 2023-06-30 | 4.00 | $-7.40 | 0.00 |
| 2023-03-31 | 7.20 | $-7.60 | 0.00 |
| 2022-12-31 | 7.20 | $-7.00 | 0.00 |
| 2022-09-30 | 15.40 | $-3.40 | 0.00 |
| 2022-06-30 | 13.80 | $-0.80 | 0.00 |
| 2022-03-31 | 22.60 | $0.00 | 0.00 |
| 2021-12-31 | 40.40 | $0.60 | 67.33 |
| 2021-09-30 | 29.40 | 0 | 0.00 |
| 2021-06-30 | 30.80 | $-3.00 | 0.00 |
| 2021-03-31 | 36.80 | $-32.40 | 0.00 |
| 2020-12-31 | 23.80 | $-67.00 | 0.00 |
| 2020-09-30 | 39.40 | $-67.00 | 0.00 |
| 2020-06-30 | 83.80 | $-165.81 | 0.00 |
| 2020-03-31 | 11.40 | $-328.83 | 0.00 |
| 2019-12-31 | 40.20 | $-390.64 | 0.00 |
| 2019-09-30 | 86.40 | $-390.64 | 0.00 |
| 2019-06-30 | 116.40 | $-421.84 | 0.00 |
| 2019-03-31 | 144.00 | $-384.64 | 0.00 |
| 2018-12-31 | 192.00 | $-1,368.14 | 0.00 |
| 2018-09-30 | 180.00 | $-1,368.14 | 0.00 |
| 2018-06-30 | 348.00 | $-1,476.15 | 0.00 |
| 2018-03-31 | 864.00 | $-1,752.18 | 0.00 |
| 2017-12-31 | 1644.00 | $-1,080.11 | 0.00 |
| 2017-09-30 | 1668.00 | $-1,368.14 | 0.00 |
| 2017-06-30 | 1980.00 | $-1,536.15 | 0.00 |
| 2017-03-31 | 2604.00 | $-1,968.20 | 0.00 |
| 2016-12-31 | 2556.00 | $-1,896.19 | 0.00 |
| 2016-09-30 | 3228.00 | $-1,608.16 | 0.00 |
| 2016-06-30 | 2268.00 | $-2,640.26 | 0.00 |
| 2016-03-31 | 1968.00 | $-2,856.29 | 0.00 |
| 2015-12-31 | 2964.00 | $-3,360.34 | 0.00 |
| 2015-09-30 | 6720.00 | $-13,201.32 | 0.00 |
| 2015-06-30 | 6720.00 | $-13,681.37 | 0.00 |
| 2015-03-31 | 7800.00 | $-13,921.39 | 0.00 |
| 2014-12-31 | 6600.00 | $-14,641.46 | 0.00 |
| 2014-09-30 | 11400.00 | $-4,800.48 | 0.00 |
| 2014-06-30 | 41040.00 | $-4,440.44 | 0.00 |
| 2014-03-31 | 41640.00 | $-4,680.47 | 0.00 |
| 2013-12-31 | 35520.00 | $-4,920.49 | 0.00 |
| 2013-09-30 | 34440.00 | $-7,440.74 | 0.00 |
| 2013-06-30 | 38040.00 | $-8,040.80 | 0.00 |
| 2013-03-31 | 38040.00 | $-10,801.08 | 0.00 |
| 2012-12-31 | 34440.00 | $-14,521.45 | 0.00 |
| 2012-09-30 | 34800.00 | $-12,001.20 | 0.00 |
| 2012-06-30 | 46320.00 | $-13,681.37 | 0.00 |
| 2012-03-31 | 19800.00 | $-12,481.25 | 0.00 |
| 2011-12-31 | 11880.00 | $-9,240.92 | 0.00 |
| 2011-09-30 | 17040.00 | $-9,240.92 | 0.00 |
| 2011-06-30 | 14640.00 | $-11,401.14 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.946B | 28.18 |
| CVS Health (CVS) | United States | $90.013B | 11.19 |
| Elevance Health (ELV) | United States | $70.256B | 9.45 |
| Cencora (COR) | United States | $57.138B | 19.03 |
| DiDi Global (DIDIY) | China | $27.156B | 28.85 |
| Labcorp Holdings (LH) | United States | $22.916B | 18.22 |
| Natera (NTRA) | United States | $21.976B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.475B | 0.00 |
| ICON (ICLR) | Ireland | $14.507B | 13.96 |
| Medpace Holdings (MEDP) | United States | $12.983B | 34.36 |
| CochLear (CHEOY) | Australia | $12.561B | 0.00 |
| Solventum (SOLV) | United States | $12.531B | 12.93 |
| Viatris (VTRS) | United States | $12.452B | 4.43 |
| Revvity (RVTY) | United States | $10.611B | 18.69 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.386B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.321B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.799B | 14.80 |
| HealthEquity (HQY) | United States | $7.777B | 34.06 |
| Bausch + Lomb (BLCO) | Canada | $5.172B | 34.79 |
| Sotera Health (SHC) | United States | $4.590B | 25.65 |
| BrightSpring Health Services (BTSG) | United States | $4.106B | 31.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.466B | 79.38 |
| Surgery Partners (SGRY) | United States | $2.974B | 37.42 |
| Alignment Healthcare (ALHC) | United States | $2.951B | 0.00 |
| Concentras Parent (CON) | United States | $2.944B | 18.67 |
| Organon (OGN) | United States | $2.407B | 2.62 |
| Premier (PINC) | United States | $2.158B | 20.01 |
| Progyny (PGNY) | United States | $1.955B | 41.35 |
| Ardent Health (ARDT) | United States | $1.849B | 7.14 |
| PACS (PACS) | United States | $1.804B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.623B | 27.47 |
| Pediatrix Medical (MD) | United States | $1.436B | 9.59 |
| Teladoc Health (TDOC) | United States | $1.297B | 0.00 |
| Omada Health (OMDA) | $1.171B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.092B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.798B | 4.67 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 9.51 |
| CareDx (CDNA) | United States | $0.616B | 11.34 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| Agilon Health (AGL) | United States | $0.518B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 7.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.30 |
| Enhabit (EHAB) | United States | $0.409B | 26.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.392B | 0.00 |
| So-Young (SY) | China | $0.376B | 0.00 |
| Oncology Institute (TOI) | United States | $0.341B | 0.00 |
| LifeMD (LFMD) | United States | $0.290B | 0.00 |
| Beauty Health (SKIN) | United States | $0.274B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| ModivCare (MODV) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |